Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

New study reveals how to ‘measure’ chronic pain using brain signals

New research has shown that chronic pain can be objectively measured using brain signals, a report in The Conversation said.

According to the report, a team of researchers conducted a study using brain implants capable of recording neural signals over an extended period.


Their aim was to identify reliable markers of chronic pain severity in four patients as they went about their daily lives.

While pain is typically a subjective experience, there is still much to discover about how pain signals are processed in the brain.

Previous studies often relied on artificial settings, and the relationship between acute and chronic pain circuits remained unclear.

To investigate this further, the researchers surgically implanted electrodes in the brains of four patients experiencing post-stroke pain and phantom limb pain.

Neural signals were recorded in specific brain regions associated with planning, expectation, and emotion.

The patients were then asked to report their pain severity levels multiple times a day for up to six months.

Machine learning models were developed to analyse the recorded brain activity signals and predict the patients’ self-reported pain intensity scores.

The findings unveiled a significant connection between low-frequency brain activity in the orbitofrontal cortex and the patients’ subjective pain intensities, providing an objective measure of chronic pain.

A greater shift in low-frequency activity indicated more intense pain.

Furthermore, a comparison between chronic pain and acute pain revealed distinct brain regions involved in processing each type of pain. This experiment shed light on the differences in information processing between acute and chronic pain.

Chronic pain affects a substantial portion of the population and has a higher prevalence than conditions like diabetes, high blood pressure, or depression. It poses challenges for effective treatment and can significantly impact both physical and emotional well-being.

Improved understanding of how to measure brain activity to track pain could lead to enhanced diagnosis and the development of novel treatments, such as deep brain stimulation.

While this study offers valuable insights into using specific brain regions as objective measures of chronic pain, there is still much more to uncover.

Pain signals are likely distributed across a wider brain network, and researchers are yet to determine other brain regions that may play vital roles in reflecting subjective pain.

Additionally, it remains uncertain whether the identified signals will apply to other types of pain conditions.

Looking ahead, the researchers aim to leverage these newly discovered neural biomarkers to create personalised brain stimulation approaches for treating chronic pain disorders.

This entails developing algorithms that incorporate the identified signals to govern the timing and location of brain stimulation, similar to how a thermostat operates.

More For You

Air pollution in UK linked to thousands of deaths and chronic health conditions

A report by the Royal College of Physicians claims that air pollution was causing harm to almost every organ of the body.

iStock

Royal College of Physicians paints grim picture of air pollution in UK

Doctors warn that around 99 per cent of the population in the UK are breathing "toxic air", and around 30,000 deaths will be linked to air pollution in 2025.

The Royal College of Physicians (RCP) claimed in a report that air pollution was causing harm to almost every organ of the body, and shortening life by 1.8 years on average.

Keep ReadingShow less
Community pharmacies falling behind on data security toolkit submissions

The last date for submission is 30 June 2025.

Pic credit: iStock

Community pharmacies falling behind on data security toolkit submissions

More than 50 per cent of the community pharmacies in England have failed to complete their Data Security and Protection Toolkit 2025 with the deadline in less than two weeks.

Necessary guidance regarding the toolkit has previously been provided by Community Pharmacy England (CPE) earlier.

Keep ReadingShow less
Digital guide launched to help patients with osteoporosis

In the UK, over three million people have osteoporosis.

Pic credit: iStock

Digital guide launched to help patients with osteoporosis

The Royal Osteoporosis Society (ROS) has launched a free online service called BoneMed which is aimed to support patients with osteoporosis in taking their medicine and remove barriers to adherence.

After completing a five-minute online survey, patients will be emailed a summary of the medicine they have been prescribed and six further updates throughout the year on their medication.

Keep ReadingShow less
GPhC five-year plan to empower pharmacists, uphold public trust

GPhC's Strategic Plan 2025-30 will focus on empowering pharmacists and pharmacy technicians.

iStock

GPhC five-year plan to empower pharmacists, uphold public trust

The General Pharmaceutical Council (GPhC) launched its new plan for the next five years to uphold safety, quality and public trust in pharmacy.

The regulatory body unveiled its Strategic Plan 2025-30 during a Parliamentary event attended by pharmacy minister Stephen Kinnock on Wednesday (18).

Keep ReadingShow less
Glucose monitor and test strips on a blood sugar tracker sheet with lancets and pen device.

Medical device manufacturers will have to monitor the safety and performance of their products already in use.

iStock

Medical device regulation overhauled to improve patients' safety

Medical device manufacturers must now adhere to the UK's post-market surveillance (PMS) regulations.

The new rule came into effect on June 16, and manufacturers will have to monitor the safety and performance of their products already in use.

Keep ReadingShow less